| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 221.14B | 214.13B | 192.99B | 176.92B | 168.53B | 163.56B |
| Gross Profit | 53.61B | 48.98B | 43.26B | 41.47B | 40.46B | 40.23B |
| EBITDA | 10.46B | 10.19B | 9.44B | 8.48B | 9.36B | 8.75B |
| Net Income | 5.15B | 4.94B | 5.17B | 3.82B | 5.25B | 4.86B |
Balance Sheet | ||||||
| Total Assets | 71.38B | 71.35B | 61.87B | 58.06B | 54.53B | 51.82B |
| Cash, Cash Equivalents and Short-Term Investments | 16.45B | 16.87B | 17.14B | 15.69B | 17.03B | 16.26B |
| Total Debt | 15.42B | 14.08B | 9.21B | 9.34B | 9.36B | 9.37B |
| Total Liabilities | 38.50B | 38.77B | 31.90B | 31.30B | 29.78B | 30.55B |
| Stockholders Equity | 32.88B | 32.57B | 29.97B | 26.76B | 24.59B | 21.10B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 3.72B | 3.52B | 1.29B | 2.76B | 6.72B |
| Operating Cash Flow | 0.00 | 7.51B | 7.39B | 3.96B | 5.63B | 9.31B |
| Investing Cash Flow | 0.00 | -8.84B | -4.00B | -3.31B | -3.22B | -2.97B |
| Financing Cash Flow | 0.00 | 999.00M | -1.94B | -2.00B | -1.64B | -6.55B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥61.44B | 7.88 | ― | 2.85% | 11.38% | 4.28% | |
78 Outperform | ¥117.43B | 16.52 | ― | 1.92% | 2.30% | 26.52% | |
76 Outperform | ¥162.34B | 15.86 | ― | 1.64% | 10.13% | 23.77% | |
72 Outperform | ¥97.48B | 10.82 | ― | 1.47% | 7.75% | -1.68% | |
72 Outperform | ¥228.75B | 15.19 | ― | 2.43% | 4.48% | 13.17% | |
71 Outperform | ¥74.82B | 11.40 | ― | 1.34% | 20.50% | 10.77% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% |